BioCentury | Mar 29, 2016
Financial News

Organ-on-chip play Emulate raises $28M

Emulate Inc. (Boston, Mass.) raised $28 million in a series B round. The company plans to expand its Organ-Chip portfolio and commercialize its Human Emulation System. New investors included OS Fund, Atel Ventures, and the...
BioCentury | Sep 22, 2014
Emerging Company Profile

Emulate: Organs on chips

...plc Number of employees: 25 Funds raised: $12 million Investors: NanoDimension, Cedars-Sinai Medical Center , Hansjörg Wyss...
BioCentury | Aug 4, 2014
Finance

Organs to order

Armed with $12 million in series A cash, Emulate Inc. is developing organs-on-chips to more rapidly and reliably predict human response to medicine than traditional animal models. Last week, Emulate spun out of the Wyss...
BioCentury | Jul 29, 2014
Financial News

Emulate raises $12 million in series A

The Wyss Institute for Biologically Inspired Engineering at Harvard University spun out its organs-on-chips technology into newco Emulate Inc. (Cambridge, Mass.), which raised $12 million in a series A round led by NanoDimension. Cedars-Sinai Medical...
BioCentury | Jun 3, 2013
Company News

Campus Biotech S.A., Merck KGaA, Ecole Polytechnique Federale de Lausanne (EPFL), University of Geneva (UNIGE) other, pharmaceuticals news

Campus Biotech said the sale of the former headquarters of Merck's Merck Serono S.A. biotech division in Geneva to the consortium behind the Campus Biotech initiative has been finalized. Hansjorg Wyss, the founder of Synthes...
BioCentury | Dec 10, 2012
Company News

Campus Biotech S.A., Merck KGaA other news

A pair of billionaires made an undisclosed bid to purchase the former headquarters of Merck's Merck Serono biotech division in Geneva. Hansjorg Wyss, the founder of Synthes Inc., and Ernesto Bertarelli, the former CEO of...
BioCentury | Dec 8, 2012
Company News

Billionaires make bid for former Merck Serono headquarters

A pair of billionaires made an undisclosed bid to purchase the former headquarters of the Merck Serono biotech division of Merck KGaA (Xetra:MRK) in Geneva, Switzerland. Hansjorg Wyss, the founder of Synthes Inc., and Ernesto...
Items per page:
1 - 7 of 7
BioCentury | Mar 29, 2016
Financial News

Organ-on-chip play Emulate raises $28M

Emulate Inc. (Boston, Mass.) raised $28 million in a series B round. The company plans to expand its Organ-Chip portfolio and commercialize its Human Emulation System. New investors included OS Fund, Atel Ventures, and the...
BioCentury | Sep 22, 2014
Emerging Company Profile

Emulate: Organs on chips

...plc Number of employees: 25 Funds raised: $12 million Investors: NanoDimension, Cedars-Sinai Medical Center , Hansjörg Wyss...
BioCentury | Aug 4, 2014
Finance

Organs to order

Armed with $12 million in series A cash, Emulate Inc. is developing organs-on-chips to more rapidly and reliably predict human response to medicine than traditional animal models. Last week, Emulate spun out of the Wyss...
BioCentury | Jul 29, 2014
Financial News

Emulate raises $12 million in series A

The Wyss Institute for Biologically Inspired Engineering at Harvard University spun out its organs-on-chips technology into newco Emulate Inc. (Cambridge, Mass.), which raised $12 million in a series A round led by NanoDimension. Cedars-Sinai Medical...
BioCentury | Jun 3, 2013
Company News

Campus Biotech S.A., Merck KGaA, Ecole Polytechnique Federale de Lausanne (EPFL), University of Geneva (UNIGE) other, pharmaceuticals news

Campus Biotech said the sale of the former headquarters of Merck's Merck Serono S.A. biotech division in Geneva to the consortium behind the Campus Biotech initiative has been finalized. Hansjorg Wyss, the founder of Synthes...
BioCentury | Dec 10, 2012
Company News

Campus Biotech S.A., Merck KGaA other news

A pair of billionaires made an undisclosed bid to purchase the former headquarters of Merck's Merck Serono biotech division in Geneva. Hansjorg Wyss, the founder of Synthes Inc., and Ernesto Bertarelli, the former CEO of...
BioCentury | Dec 8, 2012
Company News

Billionaires make bid for former Merck Serono headquarters

A pair of billionaires made an undisclosed bid to purchase the former headquarters of the Merck Serono biotech division of Merck KGaA (Xetra:MRK) in Geneva, Switzerland. Hansjorg Wyss, the founder of Synthes Inc., and Ernesto...
Items per page:
1 - 7 of 7